Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
Anticancer Research · 2025
DOI: 10.21873/anticanres.17677 ↗Kurz gefasst
Fallbericht in der Zeitschrift Anticancer Research, 2025. Verfasst von Mark T J VAN Bussel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands m.v.bussel@nki.nl. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands m.v.bussel@nki.nl.
- Division Endocrinology, Department of Medicine, Center for Bone Quality, Leiden University Medical Center, Leiden, the Netherlands.
- Amsterdam University Medical Centers, Department of Laboratory Science, and Amsterdam Movement Sciences Institute, Amsterdam, the Netherlands.
- Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands.
- Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Zitieren
APA
VAN Bussel, M. T. J., Bravenboer, N., Essen, H. V., Snaebjornsson, P., Appelman-Dijkstra, N. M., Schellens, J. H., & Opdam, F. L. (2025). Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial. Anticancer Research. https://doi.org/10.21873/anticanres.17677
Vancouver
VAN Bussel MTJ, Bravenboer N, Essen HV, Snaebjornsson P, Appelman-Dijkstra NM, Schellens JH, et al. Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial. Anticancer Research. 2025. doi:10.21873/anticanres.17677
BibTeX
@article{VANBussel2025,
author = {VAN Bussel, Mark T J and Bravenboer, Nathalie and Essen, Huib VAN and Snaebjornsson, Petur and Appelman-Dijkstra, Natasha M and Schellens, Jan Hm and Opdam, Frans L},
title = {Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17677}
}
EUVIMED